COVID-19 Puts Spotlight On Adaptive Clinical Trials

One of the lasting effects of the COVID-19 pandemic is likely to be the accelerated acceptance of adaptive clinical trials.

Dr. Anthony Fauci endorsed adaptive trials when he announced the effectiveness of redelivering in treating COVID-19 patients.

“The data shows that remdesivir has a clear-cut, significant positive effect in diminishing the time to recover,” Fauci said in a White House briefing April 29.

The data came from a unique type of clinical trial launched in February and sponsored by the National Institute of Allergy and Infectious Diseases where Fauci is director. The Adaptive COVID-19 Treatment Trial (ACTT) is different from classical clinical trials in that researchers can make changes in dosing, patients and other parts of the study as the data accumulates.

That’s why, not quite two months into the study, Fauci was able to declare remdesivir effective in reducing recovery time for COVID-19 patients. Discussing the trial findings up to that point, Fauci said, “What [the trial] has proven is that a drug can block this virus.”

Adaptive clinical trial design is common in testing medical devices, but much less so in testing drugs and new therapies. Those tests are almost exclusively designed as randomized clinical trials (RCT) in which subjects are divided into at least two groups, with one receiving the new drug and a second a placebo. It’s a double-blind test meaning neither the patient nor the clinical researchers know who is getting what. Once underway, only in the rarest of situations can the process depart from the trial’s original design.

Though considered the gold standard for testing the efficacy and safety of new drugs, the RCT design has been criticized for its cost, duration and inflexibility. As long ago as 2004 the Food and Drug Administration announced a Critical Path Initiative to accelerate drug development. “Modernizing Clinical Trial Designs and Strategies” was one of the programs.

At the end of last year, the FDA issued an industry guidance for pharmaceutical and bioscience firms “on the appropriate use of adaptive designs for clinical trials.”

The guidance notes,

“Adaptive designs can provide a variety of advantages over non-adaptive designs. These advantages arise from the fundamental property of clinical trials with an adaptive design: they allow the trial to adjust to information that was not available when the trial began.

While the ACTT, first launched at the University of Nebraska Medical Center and now involving 68 sites, and other adaptive COVID-19 trials now underway are showing they can deliver results, adaptive trials are unlikely to any time soon – or ever — become the new standard for drug testing.

Dr. Adams Dudley, a drug safety expert at UC San Francisco, told the Los Angeles Times, it’s risky to allow companies with a financial stake in the outcome to change study rules during a trial. However, in a crisis like the current COVID-19 pandemic, Dudley said randomized clinical trials take too long.

Noted the Times, “With thousands of people dying every day of COVID-19, the deliberate pace of this gold standard research may not be the best way to end the crisis quickly.”

Photo by Viki Mohamad on Unsplash

#WeAreGreenKey: Spotlight on Reilly Hickey
General Interest Green Key News Human Resources Professional Support Worklife

#WeAreGreenKey: Spotlight on Reilly Hickey

Green Key Unlocked: Keys to Success in Agency Recruiting
General Interest Green Key News Worklife

Green Key Unlocked: Keys to Success in Agency Recruiting

Resume Tricks for 2022
General Interest Green Key News Worklife

Resume Tricks for 2022

#WeAreGreenKey: Spotlight on Kornelia Klukowska
Accounting + Finance General Interest Green Key News Worklife

#WeAreGreenKey: Spotlight on Kornelia Klukowska

When to Say Goodbye to a Candidate
General Interest Green Key News Worklife

When to Say Goodbye to a Candidate

#WeAreGreenKey: Spotlight on Allison Vogt
General Interest Green Key News Worklife

#WeAreGreenKey: Spotlight on Allison Vogt

Green Key Unlocked: The Growth of Professional Support
General Interest Green Key News Professional Support Worklife

Green Key Unlocked: The Growth of Professional Support

#WeAreGreenKey: Spotlight on Brittany Leader
General Interest Green Key News Healthcare Worklife

#WeAreGreenKey: Spotlight on Brittany Leader

Green Key Unlocked: FAQs of Working with a Recruiter
General Interest Green Key News Pharma Worklife

Green Key Unlocked: FAQs of Working with a Recruiter

Green Key Announces New Senior Partners
General Interest Green Key News Worklife

Green Key Announces New Senior Partners

Green Key Against Gun Violence
General Interest Green Key News

Green Key Against Gun Violence

How to Support Mental Health in the Workplace
General Interest Green Key News Worklife

How to Support Mental Health in the Workplace

#WeAreGreenKey: Spotlight on Larry Goodman
General Interest Green Key News Pharma Worklife

#WeAreGreenKey: Spotlight on Larry Goodman

#WeAreGreenKey: Spotlight on Mike Glock
Accounting + Finance Financial Services General Interest Worklife

#WeAreGreenKey: Spotlight on Mike Glock

How to Make Your Candidate an Attractive Offer
General Interest Green Key News Worklife

How to Make Your Candidate an Attractive Offer

Tips for Recent Grads
General Interest Green Key News Worklife

Tips for Recent Grads

#WeAreGreenKey: Spotlight on Patrick Friel
Accounting + Finance General Interest Green Key News Worklife

#WeAreGreenKey: Spotlight on Patrick Friel

Working Moms at GKR
General Interest Green Key News Healthcare Human Resources Pharma Professional Support Worklife

Working Moms at GKR

Green Key Resources Opens New Jersey Office
General Interest Green Key News Worklife

Green Key Resources Opens New Jersey Office

#WeAreGreenKey: Spotlight on Tim Durkin
Accounting + Finance General Interest Green Key News Worklife

#WeAreGreenKey: Spotlight on Tim Durkin

Latest Blog Posts
View All Posts
#WeAreGreenKey: Spotlight on Reilly Hickey

#WeAreGreenKey: Spotlight on Reilly Hickey

Reilly graduated from Pace University in 2018 with a degree in Arts & Entertainment Management. She worked in casting for...
Read More
Green Key Unlocked: Keys to Success in Agency Recruiting

Green Key Unlocked: Keys to Success in Agency Recruiting

Becoming a successful recruiter is no easy feat. Staffing is an industry that requires specific skills and persistence in order...
Read More
Resume Tricks for 2022

Resume Tricks for 2022

To keep you on top of the resume trends, we've put together a comprehensive list of tricks and tips to...
Read More